Bone densitometry firm Hologic of Waltham, MA, said thatdemandfor its Acclaim fanbeam bone measurement devices contributed toa doubling of revenue and a sharp spike in net income in its secondquarter (end-March). Hologic posted revenues of $18.8
Bone densitometry firm Hologic of Waltham, MA, said thatdemandfor its Acclaim fanbeam bone measurement devices contributed toa doubling of revenue and a sharp spike in net income in its secondquarter (end-March).
Hologic posted revenues of $18.8 million for the quarter, comparedwith $9 million in the second quarter of 1995. Net income forthe most recent period stood at $3 million, compared with netincome of $154,000 in the same period last year. Hologic has alsoamassed a war chest of $57.9 million in cash and cash equivalents,compared with $7.4 million in cash last year.
The news sent Hologic's stock up $2 a share to close at $32.50on May 2. Shares of bone densitometry rival Lunar fell sharply,losing $3.50 a share to close at $36.50.
Study Reaffirms Low Risk for csPCa with Biopsy Omission After Negative Prostate MRI
December 19th 2024In a new study involving nearly 600 biopsy-naïve men, researchers found that only 4 percent of those with negative prostate MRI had clinically significant prostate cancer after three years of active monitoring.
Study Examines Impact of Deep Learning on Fast MRI Protocols for Knee Pain
December 17th 2024Ten-minute and five-minute knee MRI exams with compressed sequences facilitated by deep learning offered nearly equivalent sensitivity and specificity as an 18-minute conventional MRI knee exam, according to research presented recently at the RSNA conference.
Can Radiomics Bolster Low-Dose CT Prognostic Assessment for High-Risk Lung Adenocarcinoma?
December 16th 2024A CT-based radiomic model offered over 10 percent higher specificity and positive predictive value for high-risk lung adenocarcinoma in comparison to a radiographic model, according to external validation testing in a recent study.